ARTICLE | Clinical News
Feraheme ferumoxytol: Post-marketing study data
February 15, 2010 8:00 AM UTC
A safety update for IV Feraheme showed that 40 serious adverse events, including hypotension and anaphylactoid reactions, have been reported out of the estimated 35,000 patient exposures since the dru...